News

Inhal Pharma Completed 50 million Yuan in Round A Financing

Suzhou Inhal Pharma Co., Ltd., a leading domestic innovative dry powder inhalation (DPI) company, successfully completed round A financing, raising more than 50-million-yuan RMB (about US $6.8 mn) in funds.

InhalPharma Released the Self-Developed Reservoir Type DPI

InhalPharma, as the sponsor of 13th CIS-ASIA, released the self-developed Reservoir Type Dry Powder Inhalation device for the first time in the "Inhalation Development" forum.

Prof Zhu Jingxu was Awarded the AIChE PTF Award for Lifetime Achievements

Prof Zhu was awarded the Elsevier Particle Technology Forum Award for Lifetime Achievements. This award is judged by Particle Technology Forum(PTF), American Institute of Chemical Engineers.

: Academician Zhu Jingxu, Visited Kelun Pharmaceutical Research Institute 2022-07-15 Academician Zhu led the InhalPharma delegation to visit Sichuan Kelun Pharmaceutical Research Institute Co., Ltd. in Chengdu, and received warm welcome from the institute officials.

View details

: Prof Zhu Delivered an Academic Presentation at Chinese Pharmaceutical University 2021-11-12 Prof Zhu brought a seminar entitled "Microparticles Technology Boosts Medical Innovation" to the teachers and students of Chinese Pharmaceutical University(CPU).

View details

: Inhal Pharma was Approved to Establish an Academician Workstation! 2021-09-24 With the approval of the Ningbo Science and Technology Association, "Ningbo Inhal Pharma Co., Ltd. Academician Workstation" was successfully established. The establishment of the Academician Workstation will better promote Inhal Pharma to cultiv

View details

: Inhal Pharma Suzhou R&D Center Officially Launched! 2021-09-17 On September 5, 2021, under the witness of all the leaders, Ningbo Inhal Pharma Co., Ltd. officially opened its Suzhou R&D Center in Suzhou Institute of Pharmaceutical Innovation, Shanghai Institute of Materia Medica, Chinese Academy of Sciences.

View details

: Inhal Pharma Successfully Listed on the Ningbo Equity Exchange Center 2021-02-06 On February 3, 2021, Ningbo Inhal Pharma Co., Ltd. was successfully listed on the Young Entrepreneur Innovation Board (Ticker: 782865P) in Ningbo Equity Exchange Center (NEEC), which represents the recognition of Inhal Pharma by NEEC.

View details

: Copley Experts Provided NGI Training for Inhal Pharma 2021-01-07 Inhal Pharma invited Tony McDonough from Copley to give a 2-day NGI technical training for the DPI project team. In this training, Mr Tony McDonough compared the testing standards of inhalation formulations in the Chinese, the United States and the Europe

View details

News

News

Inhal Pharma Completed 50 million Yuan in Round A Financing

InhalPharma Released the Self-Developed Reservoir Type DPI

Prof Zhu Jingxu was Awarded the AIChE PTF Award for Lifetime Achievements

Inhal Pharma Completed 50 million Yuan in Round A Financing

InhalPharma Released the Self-Developed Reservoir Type DPI

Prof Zhu Jingxu was Awarded the AIChE PTF Award for Lifetime Achievements

+86 (574) 8708-5448

yyy@inhalpharma.com

Ms. Yao

Bldg A1, No. 2660, Yongjiang Ave, High-tech Zone, Ningbo, 315040, Zhejiang Province, China